Evaluation of PK and Biomarkers After UDCA Administrations to Subjects Who Are Overweight and Have Liver Problems

NCT03000218 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Overweight
Abnormal Liver Function Tests

Interventions

DRUG: Ursodeoxycholic acid
DRUG: Metformin
DRUG: Placebo

Sponsor

Seoul National University Hospital